{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:09:54Z","timestamp":1793088594686,"version":"4.5.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,4]]},"DOI":"10.1093\/ecco-jcc\/jjx073","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T11:12:11Z","timestamp":1495105931000},"page":"1420-1429","source":"Crossref","is-referenced-by-count":119,"title":["Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial"],"prefix":"10.1093","volume":"11","author":[{"given":"Selina R","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis C","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio E","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda C","family":"Lomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"key":"key\n\t\t\t\t20171204111815_CIT0001","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ajg.2012.260","article-title":"Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis","volume":"107","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20171204111815_CIT0002","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171204111815_CIT0003","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1572-0241.2002.05475.x","article-title":"Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors","volume":"97","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20171204111815_CIT0004","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.MIB.0000195391.49762.89","article-title":"Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health","volume":"12","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20171204111815_CIT0005","article-title":"Irritable Bowel Syndrome in Adults: Diagnosis and Management","volume":"CG61","author":"NICE","year":"2008","journal-title":"NICE Guidelines. Manchester, UK"},{"key":"key\n\t\t\t\t20171204111815_CIT0006","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jhn.12385","article-title":"British dietetic association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults [2016 update]","volume":"29","year":"2016","journal-title":"J Hum Nutr Diet"},{"key":"key\n\t\t\t\t20171204111815_CIT0007","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3945\/jn.112.159285","article-title":"Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome","volume":"142","year":"2012","journal-title":"J Nutr"},{"key":"key\n\t\t\t\t20171204111815_CIT0008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","article-title":"A diet low in fodmaps reduces symptoms of irritable bowel syndrome","volume":"146","year":"2014","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171204111815_CIT0009","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrgastro.2013.259","article-title":"Mechanisms and efficacy of dietary fodmap restriction in IBS","volume":"11","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20171204111815_CIT0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2013.386","article-title":"Differential effects of fodmaps [fermentable oligo-, di-, mono-saccharides and polyols] on small and large intestinal contents in healthy subjects shown by MRI","volume":"109","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20171204111815_CIT0011","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1440-1746.2010.06370.x","article-title":"Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome","volume":"25","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20171204111815_CIT0012","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2036.2010.04237.x","article-title":"Dietary poorly absorbed, short\u2010chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon","volume":"31","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20171204111815_CIT0013","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2016.09.062","article-title":"Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171204111815_CIT0014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.crohns.2008.09.004","article-title":"Reduction of dietary poorly absorbed short-chain carbohydrates [fodmaps] improves abdominal symptoms in patients with inflammatory bowel disease\u2014a pilot study","volume":"3","year":"2009","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20171204111815_CIT0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/MIB.0000000000000708","article-title":"Fermentable carbohydrate restriction [low fodmap diet] in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease","volume":"22","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20171204111815_CIT0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(99)00086-8","article-title":"Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials","volume":"107","year":"1999","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171204111815_CIT0017","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cgh.2008.02.058","article-title":"Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence","volume":"6","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20171204111815_CIT0018","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn\u2019s disease","volume":"60","year":"2011","journal-title":"Gut"},{"key":"key\n\t\t\t\t20171204111815_CIT0019","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","year":"2006","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171204111815_CIT0020","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20171204111815_CIT0021","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/flgastro-2013-100420","article-title":"Utility of faecal calprotectin in inflammatory bowel disease [IBD]: What cut-offs should we apply","volume":"6","year":"2015","journal-title":"Frontline Gastroenterol"},{"key":"key\n\t\t\t\t20171204111815_CIT0022","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: Fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20171204111815_CIT0023","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1046\/j.1365-2036.1999.00610.x","article-title":"Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT","volume":"13","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20171204111815_CIT0024","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.52.5.671","article-title":"An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome","volume":"52","year":"2003","journal-title":"Gut"},{"key":"key\n\t\t\t\t20171204111815_CIT0025","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1053\/j.gastro.2005.11.058","article-title":"Design of treatment trials for functional gastrointestinal disorders","volume":"130","year":"2006","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171204111815_CIT0026","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01535722","article-title":"GSRS\u2014a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease","volume":"33","year":"1988","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t20171204111815_CIT0027","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/apt.13746","article-title":"Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome","volume":"44","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20171204111815_CIT0028","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ecco-jcc\/jjv136","article-title":"Dietary intake of inulin-type fructans in active and inactive Crohn\u2019s disease and healthy controls: A case-control study","volume":"9","year":"2015","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20171204111815_CIT0029","doi-asserted-by":"crossref","first-page":"e15591","DOI":"10.1371\/journal.pone.0015591","article-title":"Placebos without deception: A randomized controlled trial in irritable bowel syndrome","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171204111815_CIT0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1079\/BJN19950110","article-title":"Recovery of inulin from Jerusalem artichoke [Helianthus tuberosus l] in the small intestine of man","volume":"74","year":"1995","journal-title":"Br J Nutr"},{"key":"key\n\t\t\t\t20171204111815_CIT0031","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/64.3.324","article-title":"Digestion, excretion, and energy value of fructooligosaccharides in healthy humans","volume":"64","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t20171204111815_CIT0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.ejcn.1600320","article-title":"Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increase energy excretion in ileostomy subjects","volume":"51","year":"1997","journal-title":"Eur J Clin Nutr"},{"key":"key\n\t\t\t\t20171204111815_CIT0033","first-page":"305","article-title":"Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics","volume":"104","year":"2008","journal-title":"J Appl Microbiol"},{"key":"key\n\t\t\t\t20171204111815_CIT0034","first-page":"G397","article-title":"Conservation of mannitol, lactulose, and raffinose by the human colon","volume":"241","year":"1981","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t20171204111815_CIT0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.gastro.2009.10.055","article-title":"Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome","volume":"138","year":"2010","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171204111815_CIT0036","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/jhn.12144","article-title":"Dietary sorbitol and mannitol: Food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome","volume":"27","year":"2014","journal-title":"J Hum Nutr Diet"},{"key":"key\n\t\t\t\t20171204111815_CIT0037","first-page":"768","article-title":"Digestion and absorption of sorbitol, maltitol and isomalt from the small bowel. A study in ileostomy subjects","volume":"48","year":"1994","journal-title":"Eur J Clin Nutr"},{"key":"key\n\t\t\t\t20171204111815_CIT0038","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/jhn.12144","article-title":"Dietary sorbitol and mannitol: Food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome","volume":"27","year":"2014","journal-title":"J Hum Nutr Diet"},{"key":"key\n\t\t\t\t20171204111815_CIT0039","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/ejcn.2010.272","article-title":"Validation of a food frequency questionnaire to measure intakes of inulin and oligofructose","volume":"65","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"key\n\t\t\t\t20171204111815_CIT0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cgh.2008.02.058","article-title":"Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: Randomized placebo-controlled evidence","volume":"6","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20171204111815_CIT0041","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/jf802700e","article-title":"Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography [HPLC]","volume":"57","year":"2009","journal-title":"J Agric Food Chem"},{"key":"key\n\t\t\t\t20171204111815_CIT0042","first-page":"541","article-title":"Effect of inulin on the human gut microbiota: stimulation of bifidobacterium adolescentis and faecalibacterium prausnitzii","volume":"101","year":"2009","journal-title":"Br J Nutr"},{"key":"key\n\t\t\t\t20171204111815_CIT0043","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1017\/jns.2014.68","article-title":"A randomised, double-blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects","volume":"4","year":"2015","journal-title":"J Nutr Sci"},{"key":"key\n\t\t\t\t20171204111815_CIT0044","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1017\/S0007114515001889","article-title":"Influence of galacto-oligosaccharide mixture [B-GOS] on gut microbiota, immune parameters and metabonomics in elderly persons","volume":"114","year":"2015","journal-title":"Br J Nutr"},{"key":"key\n\t\t\t\t20171204111815_CIT0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/10408398.2012.656772","article-title":"Immunological properties of inulin-type fructans","volume":"55","year":"2015","journal-title":"Crit Rev Food Sci Nutr"},{"key":"key\n\t\t\t\t20171204111815_CIT0046","doi-asserted-by":"crossref","first-page":"S-587","DOI":"10.1016\/S0016-5085(14)62126-0","article-title":"Mo1210 low fodmap diet reduces irritable bowel symptoms and improves quality of life in patients with inflammatory bowel disease in a randomized controlled trial","volume":"146","year":"2014","journal-title":"Gastroenterology"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/11\/12\/1420\/22188899\/jjx073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T06:00:51Z","timestamp":1719208851000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article\/11\/12\/1420\/3835798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,14]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,6,14]]},"published-print":{"date-parts":[[2017,12,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx073","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,6,14]]}}}